Noblett Karen's Form 4 filing
Axonics, Inc. (AXNX) · filed Dec 28, 2023
- Accession no.
- 0001562180-23-008578
- Filed
- Dec 28, 2023
- Trade date
- Dec 26-28, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $506.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Noblett KarenCIK 0001756240 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 26, 2023 | Common Stock | SSaleDisposed | −949 | $63.00 | −$59,787 | 41,266 | Direct | |
| Dec 28, 2023 | Common Stock | SSaleDisposed | −7,051 | $63.28F2 | −$446,187.28 | 34,215 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $63.00 to $63.8425. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.